Background: The natural course of idiopathic membranous nephropathy (MN) varies, as it is
known through favorable outcomes in most patients. However, one third of patients with …

Autoantibodies to the M-type phospholipase A 2 receptor (PLA 2 R) are sensitive and
specific for idiopathic membranous nephropathy. The anti-B cell agent rituximab is a …

The M-type receptor for phospholipase A2 (PLA2R1) is the major target antigen in idiopathic
membranous nephropathy (iMN). Our recent genome-wide association study showed that …

Background. The recent finding that phospholipase-A2-receptor antibodies (PLA2R-AB)
may play a role in the development of primary membranous glomerulonephritis (MGN) offers …

Patients with primary membranous nephropathy (MN) who experience spontaneous
remission of proteinuria generally have an excellent outcome without need of …

Membranous nephropathy (MN) accounts for most cases of the nephrotic syndrome in
adults. Recently, studies on the underlying pathomechanisms led to the identification of the …

The identification of circulating autoantibodies against the M-type phospholipase A₂
receptor (anti-PLA₂R) in patients with idiopathic membranous nephropathy (iMN) has been …

Background. The recent identification of circulating autoantibodies directed towards the M‐
type phospholipase A2 receptor (PLA2R) has been a major advancement in the serological …

The discovery in 2009 of the M-type phospholipase A2 receptor (PLA2R) as the primary
target in membranous nephropathy (MN) greatly advanced basic and clinical research …

The data were presented in abstract form at the 45th meeting of the American Society of
Nephrology, October 30-November 04 2012, San Diego, CA, USA. Circulating …